These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6534547)

  • 1. Compression properties of cephalexin powder and physical properties of the tablet.
    Kaneniwa N; Imagawa K; Otsuka M
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4986-93. PubMed ID: 6534547
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of temperature on the tensile strength of pharmaceutical powders.
    Britten JR; Pilpel N
    J Pharm Pharmacol; 1978 Nov; 30(11):673-7. PubMed ID: 31427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tabletting on the degree of crystallinity and on the dehydration and decomposition points of cephalexin crystalline powder.
    Kaneniwa N; Imagawa K; Otsuka M
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):802-9. PubMed ID: 4017125
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relationship between dividing properties of scored tablets and dynamic characteristics of powder].
    Ito A; Sugihara M
    Yakugaku Zasshi; 1991 Oct; 111(10):606-11. PubMed ID: 1812281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous modeling prediction of three key quality attributes of tablets by powder physical properties.
    Jin C; Zhao L; Feng Y; Hong Y; Shen L; Lin X
    Int J Pharm; 2022 Nov; 628():122344. PubMed ID: 36341919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple predictive model for the tensile strength of binary tablets.
    Wu CY; Best SM; Bentham AC; Hancock BC; Bonfield W
    Eur J Pharm Sci; 2005 Jun; 25(2-3):331-6. PubMed ID: 15911230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting.
    Osei-Yeboah F; Chang SY; Sun CC
    Pharm Res; 2016 May; 33(5):1126-32. PubMed ID: 26767997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of compression characteristics of powders.
    Fell JT; Newton JM
    J Pharm Sci; 1971 Sep; 60(9):1428-9. PubMed ID: 5567600
    [No Abstract]   [Full Text] [Related]  

  • 13. Preformulation studies in a drug development program for tablet formulations.
    Graffner C; Johansson ME; Nicklasson M; Nyqvist H
    J Pharm Sci; 1985 Jan; 74(1):16-20. PubMed ID: 3981410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the tensile strength of compacted multi-component mixtures of pharmaceutical powders.
    Wu CY; Best SM; Bentham AC; Hancock BC; Bonfield W
    Pharm Res; 2006 Aug; 23(8):1898-905. PubMed ID: 16850273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the effect of the binding agent and compression pressure on the properties of granulates and tablets prepared by fluidization and pulverization].
    Salama AH; Kovács B; Gyarmathy M; Gyarmati L
    Acta Pharm Hung; 1976 Jan; 46(1):24-30. PubMed ID: 1258649
    [No Abstract]   [Full Text] [Related]  

  • 16. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
    Hirschberg C; Sun CC; Rantanen J
    J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Note on the Use of Diametrical Compression to Determine Tablet Tensile Strength.
    Hilden J; Polizzi M; Zettler A
    J Pharm Sci; 2017 Jan; 106(1):418-421. PubMed ID: 27686682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties.
    Otsuka M; Matsuda Y; Kokubo T; Yoshihara S; Nakamura T; Yamamuro T
    J Biomed Mater Res; 1995 Jan; 29(1):33-8. PubMed ID: 7713956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.